Detalhe da pesquisa
1.
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
N Engl J Med
; 384(6): 541-549, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567193
2.
New viral vectors for infectious diseases and cancer.
Semin Immunol
; 50: 101430, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262065
3.
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.
Int J Mol Sci
; 22(24)2021 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948316
4.
Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.
Int J Mol Sci
; 22(2)2021 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418877
5.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med
; 376(10): 928-938, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426834
6.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
7.
Antigen-specific CD8 T cells in cell cycle circulate in the blood after vaccination.
Scand J Immunol
; 89(2): e12735, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488973
8.
A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
J Virol
; 91(10)2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28250120
9.
Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.
J Urban Health
; 95(1): 99-110, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204843
10.
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Hepatology
; 63(5): 1442-54, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26513111
11.
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
Hepatology
; 63(5): 1455-70, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474390
12.
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
Mol Ther
; 24(8): 1470-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109630
13.
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.
Gut
; 65(12): 2029-2034, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26306759
14.
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.
J Gen Virol
; 97(1): 82-94, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519290
15.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336730
16.
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.
J Biol Chem
; 289(50): 35015-28, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342747
17.
Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model.
J Antimicrob Chemother
; 70(6): 1784-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656410
18.
Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.
J Virol
; 88(3): 1725-39, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24257605
19.
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
J Virol
; 88(21): 12644-55, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142595
20.
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
J Virol
; 88(10): 5502-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599994